PUS1 Gene Mitochondrial Myopathy and Sideroblastic Anemia Type 1 Genetic Test
Test Name: PUS1 Gene Mitochondrial Myopathy and Sideroblastic Anemia Type 1 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for PUS1 Gene Mitochondrial Myopathy and Sideroblastic Anemia Type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PUS1 Gene Mitochondrial Myopathy and Sideroblastic Anemia Type 1.
Test Details
The PUS1 gene is associated with a condition called mitochondrial myopathy and sideroblastic anemia type 1. Mitochondrial myopathy refers to a group of disorders that affect the mitochondria, which are responsible for producing energy in the cells. Sideroblastic anemia is a condition characterized by an impaired ability of the bone marrow to produce healthy red blood cells.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or the entire genome. It uses high-throughput sequencing technology to rapidly sequence DNA samples and identify variations or mutations in the genes of interest.
In the context of mitochondrial myopathy and sideroblastic anemia type 1, NGS genetic testing can be used to analyze the PUS1 gene for any disease-causing mutations or variations. This can help in diagnosing individuals with this specific genetic condition and provide valuable information for their medical management and treatment.
It is important to note that genetic testing should always be performed and interpreted by qualified healthcare professionals who can provide appropriate genetic counseling and guidance based on the results.
| Test Name | PUS1 Gene Mitochondrial myopathy and sideroblastic anemia type 1 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for PUS1 Gene Mitochondrial myopathy and sideroblastic anemia type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PUS1 Gene Mitochondrial myopathy and sideroblastic anemia type 1 |
| Test Details | The PUS1 gene is associated with a condition called mitochondrial myopathy and sideroblastic anemia type 1. Mitochondrial myopathy refers to a group of disorders that affect the mitochondria, which are responsible for producing energy in the cells. Sideroblastic anemia is a condition characterized by an impaired ability of the bone marrow to produce healthy red blood cells. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or the entire genome. It uses high-throughput sequencing technology to rapidly sequence DNA samples and identify variations or mutations in the genes of interest. In the context of mitochondrial myopathy and sideroblastic anemia type 1, NGS genetic testing can be used to analyze the PUS1 gene for any disease-causing mutations or variations. This can help in diagnosing individuals with this specific genetic condition and provide valuable information for their medical management and treatment. It is important to note that genetic testing should always be performed and interpreted by qualified healthcare professionals who can provide appropriate genetic counseling and guidance based on the results. |
